SCHEMBL8899239

SCHEMBL8899239

COc1cccc(Nc2nc(Nc3ccc(CNS(C)(=O)=O)cc3)nc3ccccc23)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 5/20 0.60
KDM4E B2RXH2 2/20 0.57
HTT P42858 2/20 0.57
TAAR1 Q96RJ0 1/20 0.57
SLC2A1 P11166 1/20 0.57
ABCG2 Q9UNQ0 7/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
ABCB1 P08183 5/20 0.53
PDE5A O76074 2/20 0.53
MERTK Q12866 1/20 0.51
PAK4 O96013 1/20 0.51
PAK1 Q13153 1/20 0.51
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8907685 0.99 NPY5R (0.59) NPY5RKDM4EHTTTAAR1SLC2A1
SCHEMBL8901783 0.91 NPY5R (0.69) NPY5RSLC2A1ABCG2MEN1KMT2A
Hydrochloric Acid SCHEMBL8889859 0.90 NPY5R (0.68) NPY5RSLC2A1ABCG2MEN1KMT2A
Hydrochloric Acid SCHEMBL8912533 0.88 NPY5R (0.68) NPY5RSLC2A1PDE5A
SCHEMBL8900016 0.86 NPY5R (0.61) NPY5RKDM4EHTTTAAR1SLC2A1
SCHEMBL8891464 0.85 NPY5R (0.69) NPY5RKDM4EHTTTAAR1SLC2A1
SCHEMBL8891851 0.85 NPY5R (0.78) NPY5RKDM4EHTTTAAR1ABCG2
SCHEMBL8901142 0.84 NPY5R (0.51) NPY5RSLC2A1
Hydrochloric Acid SCHEMBL8890929 0.84 NPY5R (0.67) NPY5RKDM4EHTTTAAR1SLC2A1
Hydrochloric Acid SCHEMBL8899399 0.84 NPY5R (0.76) NPY5RKDM4EHTTTAAR1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed